Equity Investment (Details Narrative) - USD ($)		12 Months Ended
Jun. 09, 2022	Jun. 30, 2022	Jun. 30, 2021
Equity Investment contribution		$ 4,000,000	$ 0
Cash balance		3,800,000
Equity in loss from equity investment		(22,000)
Incurred a loss of BTL		$ 63,000
BT BeaMedical Technologies Limited ("BTL") [Member] \| Purchase Agreement [Member]
Description of Equity Investment	a company established under the laws of the State of Israel (“BTL”), pursuant to which the Company purchased 55,556 shares of BTL’s Series A Redeemable Preferred Shares (the “Series A Shares”) and a warrant to purchase 27,778 Series A Shares for aggregate consideration of $4,000,000, or approximately $72.00 per Series A Share. Following the closing under the Purchase Agreement, the Company owns approximately 35.7% of BTL’s issued and outstanding equity securities and approximately 41.6% of BTL’s equity securities on a fully diluted basis.

3,800,000

$ 63,000

a company established under the laws of the State of Israel (“BTL”), pursuant to which the Company purchased 55,556 shares of BTL’s Series A Redeemable Preferred Shares (the “Series A Shares”) and a warrant to purchase 27,778 Series A Shares for aggregate consideration of $4,000,000, or approximately $72.00 per Series A Share. Following the closing under the Purchase Agreement, the Company owns approximately 35.7% of BTL’s issued and outstanding equity securities and approximately 41.6% of BTL’s equity securities on a fully diluted basis.